Company Filing History:

5 out of 33

Egis Gyogyszergyar Rt.

Egis Gyogyszergyar Nyrt

patents

Years Active: 1997-2011

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7960375 - 8-chloro-2,3-benzodiazepine derivatives (2011-06-14),

2. 7786129 - Piperazine derivatives of dialkyl oxindoles (2010-08-31),

3. 7189711 - 2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient (2007-03-13),

4. 7098210 - 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient (2006-08-29),

5. 6930110 - Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same (2005-08-16),

6. 6130215 - Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions (2000-10-10),

7. 5652270 - Pharmaceutical compositions containing bicycloheptane ether amines and a (1997-07-29),

Title: Gábor Szénási: Innovator in Pharmaceutical Chemistry

Introduction

Gábor Szénási is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 7 patents to his name, Szénási's work focuses on developing new compounds that have potential therapeutic applications.

Latest Patents

One of Szénási's latest patents involves the creation of piperazine derivatives of dialkyl oxindoles. This invention is concerned with new 3,3-disubstituted indol-2-one derivatives that are useful in treating diseases of the central nervous system, gastrointestinal system, and cardiovascular system. Another significant patent pertains to novel 2,3-benzodiazepine derivatives, which exhibit antispasmodic, muscle relaxant, and neuroprotective activities. These compounds are formulated to enhance their efficacy as active ingredients in pharmaceutical compositions.

Career Highlights

Throughout his career, Gábor Szénási has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár Rt. and Egis Gyógyszergyár Nyrt. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.

Collaborations

Szénási has collaborated with notable colleagues in his field, including József Barkóczy and György Lévay. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.

Conclusion

Gábor Szénási's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.